Vaccine developer stocks rise as flu activity escalates
-- Shares of vaccine developers, including Moderna (NASDAQ:MRNA) and CureVac, have seen an uptick in premarket trading on Monday as the seasonal flu activity...
-- Shares of vaccine developers, including Moderna (NASDAQ:MRNA) and CureVac, have seen an uptick in premarket trading on Monday as the seasonal flu activity...
-- European stock markets traded higher Monday, boosted by a modest recovery in the region's services industry ahead of the release of key US employment data. At...
-- Shares of T-Mobile US (NASDAQ:TMUS), Inc. fell on Monday following a double downgrade by RBC Capital Markets and Wells Fargo (NYSE:WFC), both of which expressed...
-- RBC Capital unveiled its "Top 30 Global Ideas for 2025," highlighting high-conviction, long-term investment opportunities. This quarterly updated list features...
By Lisa Richwine LOS ANGELES (Reuters) - Netflix (NASDAQ:NFLX)'s next venture into live programming starts Monday when the company streams its first episode of "Raw," the weekly ...
-- JPMorgan strategists project that European equities will continue to underperform their US counterparts in 2025, as the group remains weighed down by subdued...
Monday saw the U.S. dollar maintaining its upward trajectory, continuing the trend from the holiday season and defying traditional seasonal patterns. Despite a brief upswing in...
By Dawn Chmielewski (Reuters) - Three major media companies will ask the U.S. Court of Appeals on Monday to reverse a ruling that blocked the launch of their Venu Sports streaming...
-- Despite a cautious end to 2024, UBS analysts project that the stock market rally will persist in 2025, driven by several positive factors. The MSCI All Country...
A look at the day ahead in U.S. and global markets from Mike Dolan The first full trading week of 2025 kicks off with markets positioning for the Jan. 20 inauguration of Donald...